AVITA Medical, Inc. (RCEL)
10.77
+0.70
(+6.95%)
USD |
NASDAQ |
Sep 02, 16:00
10.77
0.00 (0.00%)
After-Hours: 20:00
AVITA Medical Cash and Short Term Investments (Quarterly) : 11.14M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.14M |
| March 31, 2026 | 14.26M |
| December 31, 2025 | 18.18M |
| September 30, 2025 | 23.31M |
| June 30, 2025 | 15.69M |
| March 31, 2025 | 25.82M |
| December 31, 2024 | 35.88M |
| September 30, 2024 | 44.40M |
| June 30, 2024 | 54.06M |
| March 31, 2024 | 68.18M |
| December 31, 2023 | 89.06M |
| September 30, 2023 | 60.12M |
| Date | Value |
|---|---|
| June 30, 2023 | 66.05M |
| March 31, 2023 | 73.45M |
| December 31, 2022 | 79.34M |
| September 30, 2022 | 84.37M |
| June 30, 2022 | 84.56M |
| March 31, 2022 | 83.57M |
| June 30, 2021 | 110.95M |
| March 31, 2021 | 115.08M |
| December 31, 2020 | 59.97M |
| September 30, 2020 | 65.95M |
| June 30, 2020 | 73.84M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 231.00M |
| Iovance Biotherapeutics, Inc. | 297.67M |
| Editas Medicine, Inc. | 211.64M |
| Arcus Biosciences, Inc. | 702.00M |
| Recursion Pharmaceuticals, Inc. | 551.07M |